Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Chemical Makers Strengthens Overseas Medical Business To Offset Sluggish Chemical Demand

This article was originally published in PharmAsia News

Executive Summary

Amid the worldwide recession, several Japanese chemical companies strengthened their medical businesses to offset a sluggish demand for chemical and optical products. Asahi Chemical signed a co-development and promotion deal with Nagano-based medical device maker Misuzu Sun Medical Holdings for Evaheart left ventricular assist system for congestive heart failure patients in overseas markets. The company has submitted an application with FDA to start clinical trials in the U.S. Trials are also being planned in Europe in 2011. The company estimates ¥25 billion in sales by 2020. Sekisui Chemical is in negotiations to acquire a mid-sized U.S. company and expand its diabetes testing agent market. Teijin established a joint venture in Spain this February to strengthen its home care device business. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071417

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel